Navidea Biopharmaceuticals Inc logo

Navidea Biopharmaceuticals Inc

$ 0.26 -0.00995 (-3.69%) 03:59 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 7.89M
Enterprise V:
$ 8.71M
Volume:
100.60K
Avg Vol (2M):
210.93K
Also Trade In:
Volume:
100.60K
Market Cap $:
7.89M
PE Ratio:
At Loss
Avg Vol (2-Month):
210.93K
Enterprise Value $:
8.71M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
Name Current Vs Industry Vs History
Cash-To-Debt 0.39
Equity-to-Asset -1.81
Debt-to-Equity -0.19
Debt-to-EBITDA -0.07
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -227.68
Distress
Grey
Safe
Beneish M-Score -10.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 67.85
9-Day RSI 48.45
14-Day RSI 38.53
6-1 Month Momentum % -60.02
12-1 Month Momentum % -82.42

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.22
Quick Ratio 0.16
Cash Ratio 0.06
Days Sales Outstanding 1052.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -44.6

Financials (Next Earnings Date:2022-11-10 Est.)

NAVB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:NAVB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.017
EPS (TTM) ($) -0.4
Beta 1.24
Volatility % 59.43
14-Day RSI 38.53
14-Day ATR ($) 0.031014
20-Day SMA ($) 0.267758
12-1 Month Momentum % -82.42
52-Week Range ($) 0.225 - 1.83
Shares Outstanding (Mil) 30.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Navidea Biopharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Navidea Biopharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.